Filing Flows › Evolent Health (EVH) › Q2 2026
Evolent Health (EVH) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 6, 2026
Evolent Health (EVH) reported revenue of $653M for the second quarter 2026 (Q2 2026), +47% from a year earlier and +31% from the quarter before. Operating margin was -1.5%, net loss $28.4M (4.3% of revenue).
Evolent Health, Q2 2026: revenue $653M (+47% year over year), operating margin -1.5%, net loss $28.4M, operating cash flow −$9.3M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $653M | +31% | +47% |
| Operating profit | −$9.6M | — | — |
| Net earnings | −$28.4M | — | — |
| Operating cash flow | −$9.3M | — | — |
What changed
Revenue was $652.5M in Q2 2026, up 47% year over year and up 31% from the previous quarter.
Operating costs exceeded revenue by $9.6M, an operating margin of -1.5%. Total costs grew 49% against revenue growth of 47%. The fastest-growing cost line was Cost of revenue (+66%). The quarter ended with a net loss of $28.4M, wider than the previous quarter's $26.6M loss. Net interest and other expense of $16.1M was the main reason.
Operating cash flow was −$9.3M. Non-cash charges added back $21.6M of depreciation and amortization and $15.2M of share-based compensation. Working capital and other items used $17.7M.
Questions
What was Evolent Health's revenue in the second quarter 2026?
Evolent Health (EVH) reported revenue of $653M for the second quarter 2026 (Q2 2026), +47% from a year earlier and +31% from the quarter before.
Was Evolent Health profitable in the second quarter 2026?
Operating loss was $9.6M (-1.5% of revenue) and net loss $28.4M.
Source: Evolent Health 10-Q on SEC EDGAR.